Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric radiologically confirmed community acquired pneumonia following PCV7 introduction in Switzerland

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Chappuy, Hélène ^a,f   Keitel, Kristina ^a   Gehri, Mario ^b   Tabin, René ^c   Robitaille, Lynda ^d   Raymond, Frederic ^d   Corbeil, Jacques ^d   Maspoli, Veronica ^a   Bouazza, Naim ^e   Alcoba, Gabriel ^a   Lacroix, Laurence ^a   Manzano, Sergio ^a   Galetto Lacour, Annick ^a   Gervaix, Alain ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Centre Hospitalier Universitaire Vaudois   (Switzerland)

^c Hopital du Valais   (Switzerland)

^d LAVAL UNIVERSITY   (Canada)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Children; Pneumonia; Serotypes; Streptococcus pneumoniae; Vaccination

Indexed keywords

HEPTA VALENT PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; AGE; ARTICLE; CHILD; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GENDER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; SEROTYPE; SIBLING; STREPTOCOCCUS PNEUMONIAE; SWITZERLAND; THORAX RADIOGRAPHY; TOBACCO; VACCINATION;

EID: 84880955519     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-357     Document Type: Article

References (43)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, Hib and Pneumococcal Global Burden of Disease Study Team Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374:893-902. 10.1016/S0140-6736(09)61204-6, 19748398, Hib and Pneumococcal Global Burden of Disease Study Team.
2. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000, 19:187-195. 10.1097/00006454-200003000-00003, 10749457.
3. Klugman KP. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect Dis 2001, 1:85-91. 10.1016/S1473-3099(01)00063-9, 11871480.
4. Dagan R, Fraser D. Conjugate pneumococcal vaccine and antibioticresistant Streptococcus pneumoniae: herd immunity and reduction of otitis morbidity. Pediatr Infect Dis J 2000, 19:S79-S88. 10.1097/00006454-200005001-00012, 10821476.
5. Spratt BG, Greenwood BM. Prevention of pneumococcal disease by vaccination: does serotype replacement matter?. Lancet 2000, 356:1210-1211. 10.1016/S0140-6736(00)02779-3, 11072934.
6. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007, 196(9):1346-1354. 10.1086/521626, 17922399.
7. Grijalva CG, Griffin MR, Nuorti JP, Walter ND, Centers for Disease Control and Prevention (CDC) Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine -United States, 1997-2006. MMWR 2009, 58(RR-01):1-4. Centers for Disease Control and Prevention (CDC).
8. De Wals P, Robin E, Fortin E, Thibeault R, Ouakki M, Douville-Fradet M. Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada. Pediatr Infect Dis J 2008, 27(11):963-968. 10.1097/INF.0b013e31817cf76f, 18845982.
9. Koshy E, Murray J, Bottle A, Sharland M, Saxena S. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008. Thorax 2010, 65(9):770-774. 10.1136/thx.2010.137802, 20805169.
10. Durando P, Crovari P, Ansaldi F, Sticchi L, Sticchi C, Turello V, Marensi L, Giacchino R, Timitilli A, Carloni R, Azzari C, Icardi G, Collaborative Group for Pneumococcal Vaccination in Liguria Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy. Vaccine 2009, 27(25-26):3459-3462. 10.1016/j.vaccine.2009.01.052, 19200823, Collaborative Group for Pneumococcal Vaccination in Liguria.
11. Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, Kauppila J, Leinonen M, McCracken GH. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004, 113:701-707. 10.1542/peds.113.4.701, 15060215.
12. Cevey-Macherel M, Galetto-Lacour A, Gervaix A, Siegrist CA, Bille J, Bescher-Ninet B, Kaiser L, Krahenbuhl JD, Gehri M. Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr 2009, 168(12):1429-1436. 10.1007/s00431-009-0943-y, 19238436.
13. Hodges RG, Macleod CM, Bernhard WG. Epidemic pneumococcal pneumonia: III. Pneumococcal carrier studies. Am J Hyg 1946, 44:207-230.
14. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4:144-154. 10.1016/S1473-3099(04)00938-7, 14998500.
15. de Andrade AL, Pimenta FC, Brandileone MC, Laval CA, Guerra ML. Genetic relationship between Streptococcus pneumoniae isolates from nasopharyngeal and cerebrospinal fluid of two infants with pneumococcal meningitis. J Clin Microbiol 2003, 41:3970-3972. 10.1128/JCM.41.8.3970-3972.2003, 179799, 12904432.
16. Greenberg D, Givon-Lavi N, Newman N, Bar-Ziv J, Dagan R. Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric pneumonia as a means to estimate serotype disease potential. Pediatr Infect Dis J 2011, 30(3):227-233. 10.1097/INF.0b013e3181f87802, 20861756.
17. Hug S, Weibel D, Delaporte E, Gervaix A, Heininger U. Comparative coverage of supplementary and universally recommended immunizations in children at 24 months of age. Pediatr Infect Dis J 2012, 31:217-220. 10.1097/INF.0b013e31823cbaa5, 22094628.
18. WHO WHO Standardization of Interpretation of Chest Radiographs (WHO-SICR) 2001, Geneva, Switzerland: World Health Organisation, WHO/V&B/01.35. Available at: http://www.who.int/vaccine_research/diseases/ari/www616.pdf. Accessed January 20, 2012, WHO.
19. Gervaix A, Corbeil J, Raymond F. A new serotyping method of S. pneumoniae using an automated microarray-based assay. BMC Proc 2011, 5(Suppl 6):O28. Available at: http://www.biomedcentral.com/1753-6561/5/S6/O28. Accessed May 24, 2012.
20. Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, Pelton SI, Lipsitch M, Hanage WP, Lee GM, Finkelstein JA. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009, 124:e1-e11. 10.1542/peds.2008-3099, 2782668, 19564254.
21. Gray BM, Converse GM, Dillon HC. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980, 142:923-933. 10.1093/infdis/142.6.923, 7462701.
22. Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2010, 29:304-309.
23. Wiertsema SP, Kirkham LA, Corscadden KJ, Mowe EN, Bowman JM, Jacoby P, Francis R, Vijayasekaran S, Coates HL, Riley TV, Richmond P. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3 + 0 pneumococcal conjugate vaccine schedule. Vaccine 2011, 29(32):5163-5170. 10.1016/j.vaccine.2011.05.035, 21621576.
24. Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006, 25(3):250-254. 10.1097/01.inf.0000202137.37642.ab, 16511389.
25. Farrell DJ, Klugman KP, Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J 2007, 26(2):123-128. 10.1097/01.inf.0000253059.84602.c3, 17259873.
26. Grijalva CG, Pelton SI. A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children. Curr Opin Pediatr 2011, 23(1):98-104. 10.1097/MOP.0b013e328341d1f5, 3357900, 21191300.
27. Yu J, Salamon D, Marcon M, Nahm MH. Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients. J Clin Microbiol 2011, 49(2):534-538. 10.1128/JCM.01827-10, 3043489, 21123535.
28. Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J 2007, 26:461-467. 10.1097/INF.0b013e31805cdbeb, 17529859.
29. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, Butler JC, Rudolph K, Parkinson A. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007, 297:1784-1792. 10.1001/jama.297.16.1784, 17456820.
30. Moore MR, Gertz RE, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008, 197:1016-1027. 10.1086/528996, 18419539.
31. Hoberman A, Paradise JL, Shaikh N, Greenberg DP, Kearney DH, Colborn DK, Rockette HE, Kurs-Lasky M, McEllistrem MC, Zoffel LM, Balentine TL, Barbadora KA, Wald ER. Pneumococcal resistance and serotype 19A in Pittsburgh-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine. Clin Pediatr (Phila) 2011, 50:114-120.
32. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 2007, 298:1772-1778. 10.1001/jama.298.15.1772, 17940232.
33. Dagan R, Givon-Lavi N, Zamir O, Sikuler-Cohen M, Guy L, Janco J, Yagupsky P, Fraser D. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 2002, 185:927-936. 10.1086/339525, 11920317.
34. Obaro SK, Adegbola RA, Banya WA, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996, 348:271-272.
35. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A, Active Bacterial Core Surveillance of the Emerging Infections Program Network Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003, 348(18):1737-1746. 10.1056/NEJMoa022823, 12724479, Active Bacterial Core Surveillance of the Emerging Infections Program Network.
36. Marchese A, Esposito S, Coppo E, Rossi GA, Tozzi A, Romano M, Da Dalt L, Schito GC, Principi N. Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by real-time polymerase chain reaction using blood samples from Italian children ≤5 years of age with community-acquired pneumonia. Microb Drug Resist 2011, 17(3):419-424. 10.1089/mdr.2011.0031, 21510746.
37. Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, Lee HJ. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 2008, 14:275-281. 10.3201/eid1402.070807, 2600206, 18258121.
38. Dagan R, Givon-Lavi N, Leibovitz E, Greenberg D, Porat N. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis 2009, 199:776-785. 10.1086/597044, 19434927.
39. Cohen R, Levy C, Bonnet E, Grondin S, Desvignes V, Lecuyer A, Fritzell B, Varon E. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine 2010, 28(37):6114-6121. 10.1016/j.vaccine.2009.05.037, 19490958.
40. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J 2009, 28(4):277-282. 10.1097/INF.0b013e31818e0e2e, 19258924.
41. Chuck AW, Jacobs P, Tyrrell G, Kellner JD. Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines. Vaccine 2010, 28(33):5485-5490. 10.1016/j.vaccine.2010.05.058, 20554066.
42. O'Brien KL, Dagan R. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 2003, 21:1815-1825. 10.1016/S0264-410X(02)00807-1, 12706665.
43. Centers for Disease Control and Prevention (CDC) Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease: United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005, 54:893-897. Centers for Disease Control and Prevention (CDC).